Component

Human cancer-cell acetyl-CoA labeling from ALCAR

Human cancer-cell acetyl-CoA labeling from ALCAR

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. Labeled ALCAR supplied approximately 5–8% of measured cellular acetyl-CoA in the 2026 tracing experiment.

    Experimental context and source evidence
    evidence_access
    Primary full text: relevant Results/Methods and figure descriptions reviewed; supplements only where explicitly stated.
    experimental_model
    13C2-acetylcarnitine tracing; Extended Data Fig. 6a.
    interpretation_status
    Source-derived curation with stated access limits; ungraded, not independent replication.
    limitations
    Limited to the recorded preparation, model, exposure and endpoint. Does not establish a human dietary deficiency, clinical benefit or unique molecular mediation.
    nutrient_topic
    Acetyl-L-carnitine collection; exact intervention and molecular form govern interpretation. · Acetyl-L-carnitine
    plain_language
    Labeled ALCAR supplied approximately 5–8% of measured cellular acetyl-CoA in the 2026 tracing experiment.
    primary_references
    αKG-mediated carnitine synthesis drives DNA repair via histone acetylation. | https://pubmed.ncbi.nlm.nih.gov/42203879/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC13307467/ | https://doi.org/10.1038/s41586-026-10584-7
    source_locator
    Reviewed reference cancer-labeling; A fraction of a measured pool is not a whole-body uptake percentage or a flux independent of labeling time. It cannot be extrapolated to oral dosing.

    Acetyl-L-carnitine: detailed mechanisms of action (reviewed 6 October 2026) · lines 312–318

    AI-assisted original review of primary studies and clearly identified official records. Exact primary access is stated; no independent replication is claimed. · supports · 13C2-acetylcarnitine tracing; Extended Data Fig. 6a. · Recorded from source · Recorded from source

    ### cancer-labeling Labeled ALCAR supplied approximately 5–8% of measured cellular acetyl-CoA in the 2026 tracing experiment. A fraction of a measured pool is not a whole-body uptake percentage or a flux independent of labeling time. It cannot be extrapolated to oral dosing. Model and exposure: 13C2-acetylcarnitine tracing; Extended Data Fig. 6a. Limitations: Limited to the recorded preparation, model, exposure and endpoint. Does not establish a human dietary deficiency, clinical benefit or unique molecular mediation. Reference: αKG-mediated carnitine synthesis drives DNA repair via histone acetylation. | 2026 | https://pubmed.ncbi.nlm.nih.gov/42203879/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC13307467/ | https://doi.org/10.1038/s41586-026-10584-7 | Access: Primary full text: relevant Results/Methods and figure descriptions reviewed; supplements only where explicitly stated.
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.